TScan Therapeutics (TCRX) Research & Development (2020 - 2026)
TScan Therapeutics (TCRX) reported Research & Development of $23.4 million for Q2 2026, down 28.3% from $32.63 million a year earlier but up 6.8% from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Research & Development (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, TScan Therapeutics' Research & Development came in at $97.03 million, down 17.8% year-over-year; for FY2025, it came in at $114.15 million, up 6.3% from FY2024.
- Research & Development has increased for five consecutive years, with a five-year compound annual growth rate of 40.9% (FY2020 to FY2025).
- By year, Research & Development came in at $107.35 million in FY2024 (+21.8%), $88.15 million in FY2023 (+47.4%), $59.82 million in FY2022 (+33.1%) and $44.95 million in FY2021 (+118.5%).
- Five-year quarterly Research & Development spans a low of $12.61 million in Q4 2021 and a high of $32.63 million in Q2 2025.
- Year over year, Research & Development has now declined in each of the last three quarters, with growth averaging 2.7% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q3 2021 (growth of 144.4%); the low point was Q4 2025 (a decline of 31.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $21.9 million (Q1 2026), $20.04 million (Q4 2025) and $31.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 2.81 Bn |
| 10 | TScan Therapeutics | 26.76 Mn | -538.36 Mn | - | 23.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.40 Mn |
| Mar 31, 2026 | 21.90 Mn |
| Dec 31, 2025 | 20.04 Mn |
| Sep 30, 2025 | 31.69 Mn |
| Jun 30, 2025 | 32.63 Mn |
| Mar 31, 2025 | 29.79 Mn |
| Dec 31, 2024 | 29.35 Mn |
| Sep 30, 2024 | 26.26 Mn |
| Jun 30, 2024 | 26.88 Mn |
| Mar 31, 2024 | 24.86 Mn |
| Dec 31, 2023 | 22.41 Mn |
| Sep 30, 2023 | 22.74 Mn |
| Jun 30, 2023 | 21.23 Mn |
| Mar 31, 2023 | 21.78 Mn |
| Dec 31, 2022 | 15.60 Mn |
| Sep 30, 2022 | 15.03 Mn |
| Jun 30, 2022 | 14.49 Mn |
| Mar 31, 2022 | 14.69 Mn |
| Dec 31, 2021 | 12.61 Mn |
| Sep 30, 2021 | 14.21 Mn |
API Access
TScan Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();